News Page

Main Content

Cramer’s week ahead: Expect more volatility as tech earnings, midterms loom

CNBC's profile
Original Story by CNBC
October 30, 2026
Cramer’s week ahead: Expect more volatility as tech earnings, midterms loom

Context:

Stocks faced renewed volatility as AI optimism cooled heading into a busy week of earnings and midterm elections. After a brief tech-led rally, major indices retraced with the Nasdaq, S&P 500, and Dow all finishing lower on Friday, signaling that the near-term rally may stall amid uncertainty about policy, data-center spending, and key reports. Cramer advised investors not to chase a bottom in the Nasdaq and to favor high-quality names that appear beaten down, while highlighting Apple’s valuation and upcoming earnings as a critical test. The week ahead centers on Apple, AMD, Pfizer, Amgen, CVS, McDonald’s, Kimberly-Clark, and the monthly jobs report, with data-center regulation and AI spending shaping the backdrop. Outlook remains cautious, as earnings momentum and macro signals could determine how risk appetite evolves into year-end.

Dive Deeper:

  • Theweek opened with a broad equity rally driven by AI optimism, but equities gave back most gains by Friday, leaving major averages down on the close.

  • Jim Cramer warned that volatility could persist due to the upcoming midterm elections, overseas uncertainty, a jobs report, and a slate of earnings reports that could redefine market sentiment.

  • Apple is due to report after the bell, with the stock trading near record highs but valuation near 40 times earnings, creating a narrow margin for disappointment.

  • Palantir is anticipated to post encouraging results, bolstered by strong feedback on the value of its AI software, reinforcing the AI leadership narrative.

  • Data-center development could be pressured by political opposition in some states, potentially impacting AI infrastructure spending for tech and cloud developers.

  • AMD is expected to outperform Intel in the semiconductor results, serving as a key test for the sector after Intel’s weaker showing.

  • Other earnings highlights include Pfizer, Amgen, CVS Health, McDonald’s, and Kimberly-Clark, with expectations ranging from pharmaceutical earnings upside to concerns about CVS’s pharmacy benefit management moat.

Latest News

Related Stories